TechPipeline features article by Brian J. Amos, PhD, Co-Chair of the Biotech, Medtech & Pharma Practice Group and Partner at Amster Rothstein & Ebenstein LLP, and Benjy Neymotin, PhD, exploring why IP protection and commercialization are not part of researchers’ day-to-day work and how early engagement with Technology Transfer Offices can help protect IP rights while supporting publication and commercialization efforts.
Read the full article HERE. (subscription required)